This inventor holds 3 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignee: Whitehead Institute for Biomedical Research. Active years: 2014-2022.
Company Filing History:
Years Active: 2014-2022
Title: Innovations of Inventor Tong Ihn Lee
Introduction
Tong Ihn Lee is a prominent inventor based in Somerville, MA (US). He has made significant contributions to the field of biomedical research, particularly in understanding cell identity and regulatory mechanisms. With a total of three patents to his name, Lee's work has the potential to impact various medical applications.
Latest Patents
One of Tong Ihn Lee's latest patents is titled "Core transcriptional circuitry in human cells and methods of use thereof." This invention discloses methods for identifying the core regulatory circuitry or cell identity program of a cell or tissue. It also includes related methods for diagnoses, screening, and treatment involving the identified core regulatory circuitry and/or cell identity programs. Another notable patent is "Super-enhancers and methods of use thereof." This invention relates to super-enhancers and associated compositions, methods, and agents that are useful for modulating the expression of cell type-specific genes. These genes are essential for maintaining cell identity, such as embryonic stem cell identity, or for sustaining a disease state, like cancer.
Career Highlights
Tong Ihn Lee is affiliated with the Whitehead Institute for Biomedical Research, where he conducts his research. His work focuses on the intricate mechanisms that govern cell identity and function, contributing to advancements in biomedical science.
Collaborations
Lee has collaborated with notable researchers in his field, including Richard A Young and Brian J Abraham. These collaborations have further enriched his research and expanded the impact of his inventions.
Conclusion
Tong Ihn Lee's innovative work in the realm of cell identity and regulatory mechanisms showcases his significant contributions to biomedical research. His patents reflect a commitment to advancing our understanding of cellular processes and their implications for health and disease.